pfizerRD (1).jpg
Artificial IntelligenceCytoReason’s AI Earns Pfizer Extension DealCytoReason’s AI Earns Pfizer Extension Deal
The collaboration could be worth up to $110 million over the next five years.
Sign up for the QMED & MD+DI Daily newsletter.